May 27, 2025

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 13.57% Potential Upside in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the U.S. healthcare sector, operates a diversified home care platform that focuses on delivering patient-centered services. With a market capitalization of..

Phreesia, Inc. (PHR) Stock Analysis: 32% Potential Upside Amid Strong Revenue Growth

Phreesia, Inc. (PHR), a healthcare technology company that provides a comprehensive SaaS-based platform for patient intake and payments, has caught the attention of investors with its robust revenue growth and..

Azenta, Inc. (AZTA) Investor Outlook: Unpacking the 54% Potential Upside

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors, particularly given its potential upside of 54.07%..

Artivion, Inc. (AORT) Stock Analysis: Promising 13% Upside Potential Amid Healthcare Innovations

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector with its innovative approach to medical devices and implantable human tissues. With a market capitalization of $1.22 billion, this..

Addus HomeCare Corporation (ADUS): Investor Outlook with a Promising 21% Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a significant player in the healthcare sector, primarily operates within the medical care facilities industry. With a market cap of $2.06 billion, the company has..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 216.80% Potential Upside for Investors

Opko Health, Inc. (NASDAQ: OPK) presents a compelling opportunity for investors looking to dive into the dynamic healthcare sector, specifically within diagnostics and pharmaceuticals. Headquartered in Miami, Florida, Opko Health..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Promising Biotech with 139.73% Upside Potential

Ocular Therapeutix, Inc. (OCUL), a Massachusetts-based biopharmaceutical company specializing in innovative treatments for eye conditions, is increasingly capturing the attention of investors. With a market capitalization of $1.16 billion, this..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 122% Potential Upside Beckons Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the biotechnology landscape, has captured investor attention with its cutting-edge CRISPR/Cas9 gene-editing technology. Based in Zug, Switzerland, this innovative company is..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 32.41% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market cap of $1.15 billion,..

Clover Health Investments (CLOV) Stock Analysis: A 46.94% Upside Potential in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV) has been making waves in the healthcare plans sector, particularly with its innovative approach to Medicare Advantage plans. Headquartered in Wilmington, Delaware, the company..

89bio, Inc. (ETNB) Stock Analysis: Exploring the 210% Upside Potential in Biotech

89bio, Inc. (NASDAQ: ETNB), a clinical-stage biopharmaceutical company, is capturing investor attention with its impressive potential upside of over 210%. Focused on pioneering treatments for liver and cardio-metabolic diseases, 89bio..

Liquidia Corporation (LQDA): Analyst Consensus Points to a 74.59% Upside Potential

Liquidia Corporation (NASDAQ: LQDA) has recently captured the attention of investors, given its substantial upside potential. With a market capitalization of $1.31 billion, this U.S.-based biopharmaceutical company is making waves..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 46% Potential Upside Amidst Healthcare Innovations

LivaNova PLC (NASDAQ: LIVN) finds itself at an intriguing juncture that beckons attention from savvy investors. With a market capitalization of $2.28 billion, this United Kingdom-based medical technology firm is..

Viridian Therapeutics, Inc. (VRDN): Analyst Ratings Highlight 182% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and strong analyst support. With a current market cap of..

Ardent Health Partners, Inc. (ARDT) Stock Analysis: Exploring a 38.98% Potential Upside

Ardent Health Partners, Inc. (ARDT), a key player in the healthcare sector, operates a comprehensive network of hospitals and clinics across the United States. With a market capitalization of $2.09..

Alvotech (ALVO) Stock Analysis: Unveiling a 75% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, is capturing investor attention with a noteworthy potential upside of 75.10%...

Immunovant, Inc. (IMVT) Stock Analysis: Biotech with a Potential 212% Upside

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline and potential for significant upside. Focused on developing monoclonal antibodies for..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 137.5% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is making waves in the biopharmaceutical landscape with its innovative vaccine solutions. As a company focused on developing..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 69.79% Potential Upside

GoodRx Holdings, Inc. (GDRX), a key player in the healthcare sector, presents an intriguing opportunity for investors interested in the health information services industry. With a market capitalization of $1.34..

Kestra Medical Technologies (KMTS) Stock Analysis: Unveiling a Potential 23.93% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a rising star in the healthcare sector, is turning heads with its impressive revenue growth and a compelling potential upside of 23.93%. Headquartered in Kirkland,..

Search

Funds

May 27, 2025

Search

Funds

May 27, 2025

FTSE 100

Funds